DNAX — DNA Brands Share Price
Last trade - 00:00- $1.17m
- $2.10m
- $0.16m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 57.59 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -12884.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.01 | 1.17 | 1.19 | 0.25 | 0.16 | n/a | n/a | 34.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DNA Brands, Inc. is a holding company. The Company offers its products under the DNA Energy Drink brand name. The Company's offerings include Citrus, Sugar Free Citrus, Original, Cryo-Berry and Molecular Melon. Original is a combination of Red Bull and Monster energy drinks. Cryo-Berry is a mix of cranberry and raspberry. The Company offers three milk-based energy coffees fortified with Omega 3 in various flavors, such as Mocha, Vanilla Latte and Carmel Macchiato. The Company’ subsidiaries include 954Solar LLC and DNA Tags, Inc. Its 954Solar LLC is a digital marketing and solar brokerage firm. Its DNA Tags, Inc. is a third party blockchain verified technology that is used in the medicinal packaging industry.
Directors
- Last Annual
- December 31st, 2013
- Last Interim
- March 31st, 2014
- Incorporated
- May 23rd, 2007
- Public Since
- August 31st, 2005
- No. of Employees
- 10
- Sector
- Beverages
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 533,774,372
- Address
- 275 E Commercial Blvd, #208, LAUDERDALE BY THE SEA, 33308
- Web
- https://dnabrandsinc.com/
- Phone
- +1 5616545722
- Contact
- Brad Burgess
- Auditors
- Mallah- Furman- Ross & Co.
Upcoming Events for DNAX
Similar to DNAX
1812 Brewing
Pink Sheets on Nasdaq
Accredited Solutions
Pink Sheets on Nasdaq
Affinity Beverage
Pink Sheets on Nasdaq
Alkame Holdings
Pink Sheets on Nasdaq
Alternative Wellness Health
Pink Sheets on Nasdaq
FAQ
As of Today at 01:06 UTC, shares in DNA Brands are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in DNA Brands last closed at $0.00 and the price had moved by -90.87% over the past 365 days. In terms of relative price strength the DNA Brands share price has underperformed the S&P500 Index by -90.97% over the past year.
There is no consensus recommendation for this security.
DNA Brands does not currently pay a dividend.
DNA Brands does not currently pay a dividend.
DNA Brands does not currently pay a dividend.
To buy shares in DNA Brands you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in DNA Brands had a market capitalisation of $1.17m.
Here are the trading details for DNA Brands:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: DNAX
Based on an overall assessment of its quality, value and momentum DNA Brands is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DNA Brands. Over the past six months, its share price has underperformed the S&P500 Index by -45.85%.
As of the last closing price of $0.00, shares in DNA Brands were trading -73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The DNA Brands PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
DNA Brands' management team is headed by:
- Darren Marks - CHM
- Adrian McKenzie - PRE
- Bernard Rubin - DRC